Vivanza Biosciences Share Price

Vivanza Biosciences Limited, formerly known as Ivee Injectaa Limited was established in March, 1982 as a Private Limited Company and was converted into a Public Limited Company in May, 1992. Due to recessionary trends which lead to difficult business conditions in year 19992000, the parenteral industry suffered a setback and due to this, the name of the Company was changed from Ivee Injectaa Limited to Vivanza Biosciences Limited in 2015.The Company is focused in commercializing novel and generic pharmaceuticals, offering patients better, safe and more accessible medicines. It is presently engaged in the business of Pharmaceutical Products.Head quartered in Gujarat, India, Company came into existence in April 2016 to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system. Company undertook an expansioncumdiversification programme to increase its capacity from 18 lac pa to 54 lac pa. It came out with a public issue of 21,70,000 equity shares of Rs 10 each for cash at par aggregating Rs 217 lac. It is one of the few companies which has facilities for both glass as well as plastic containers. The Company acquired 100% Equity Shares of Vivanza Lifesciences Private Limited, making it a Wholly Owned Subsidiary w.e.f. 17 June, 2016.

For the full year FY2025–2026, revenue reached ₹7.48 crore and profit touched at ₹-0.67 crore.

As of 23 Dec 2025, Vivanza Biosciences share price is ₹2.1. The stock opened at ₹2 and had closed at ₹2 the previous day. During today’s trading session, Vivanza Biosciences share price moved between ₹2.04 and ₹2.09, with an average price for the day of ₹2.06. Over the last 52 weeks, the stock has recorded a low of ₹1.90 and a high of ₹3.95. In terms of performance, Vivanza Biosciences share price has declined by 1.4% over the past six months and has declined by 38.74% over the last year.